Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of CDX-6114 in Patients With Phenylketonuria (PKU)

NCT04085666 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Phenylketonuria

Interventions

DRUG: CDX 6114
OTHER: Matching Placebo

Sponsor

Société des Produits Nestlé (SPN)